{"request": {"pageUrl": "https://news.yahoo.com/flu-outbreaks-may-linked-covid-192839579.html", "api": "article", "version": 3}, "objects": [{"date": "Mon, 14 Sep 2020 00:00:00 GMT", "sentiment": 0, "images": [{"naturalHeight": 533, "width": 650, "diffbotUri": "image|3|813410756", "title": "FILE PHOTO: An illustration, created at the Centers for Disease Control and Prevention (CDC), depicts the 2019 Novel Coronavirus", "url": "https://s.yimg.com/uu/api/res/1.2/ETMJyTIb.tgcUrC6mM4yuA--~B/aD01MzM7dz04MDA7c209MTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en-US/reuters.com/dbd3060cf3448e409e19f763ad5db7d0", "naturalWidth": 800, "primary": true, "height": 432}], "author": "Nancy Lapid", "estimatedDate": "Mon, 14 Sep 2020 00:00:00 GMT", "publisherRegion": "North America", "icon": "https://s.yimg.com/os/mit/media/p/common/images/favicon_new-7483e38.svg", "diffbotUri": "article|3|1873505919", "siteName": "Yahoo! News", "type": "article", "title": "Flu outbreaks may be linked to COVID-19; arthritis drug benefit seen", "tags": [{"score": 0.9992825388908386, "sentiment": -0.944, "count": 8, "label": "influenza", "uri": "https://diffbot.com/entity/XsMQ6Svt6OwKpiB8umXB_Kw", "rdfTypes": ["http://dbpedia.org/ontology/Disease"]}, {"score": 0.9987390637397766, "sentiment": -0.908, "count": 14, "label": "COVID-19", "uri": "https://diffbot.com/entity/XkFmXKkFZMNWNCjQC5MfwUw", "rdfTypes": ["http://dbpedia.org/ontology/Disease"]}, {"score": 0.9859674572944641, "sentiment": 0, "count": 2, "label": "arthritis", "uri": "https://diffbot.com/entity/Xr4dASAuJP56lbzIYODdlbg", "rdfTypes": ["http://dbpedia.org/ontology/Disease"]}, {"score": 0.9791857600212097, "sentiment": 0.574, "count": 2, "label": "rheumatoid arthritis", "uri": "https://diffbot.com/entity/XU4LUiUkNMqmBeSvQpyddHA", "rdfTypes": ["http://dbpedia.org/ontology/Disease"]}, {"score": 0.9280024170875549, "sentiment": -0.506, "count": 2, "label": "vaccine", "uri": "https://diffbot.com/entity/Xjv_jBM9JO0KLdiTLLXaFoA", "rdfTypes": ["http://dbpedia.org/ontology/ChemicalSubstance"]}, {"score": 0.8966168165206909, "sentiment": 0, "count": 2, "label": "Italy", "uri": "https://diffbot.com/entity/As0LZKHtaPf2VSixCSIlcEg", "rdfTypes": ["http://dbpedia.org/ontology/Place", "http://dbpedia.org/ontology/PopulatedPlace", "http://dbpedia.org/ontology/Country"]}, {"score": 0.8753336668014526, "sentiment": 0, "count": 1, "label": "Gilead Sciences", "uri": "https://diffbot.com/entity/CAbvfnosGPzK3sFeexqgK5Q", "rdfTypes": ["http://dbpedia.org/ontology/Organisation"]}, {"score": 0.8372336626052856, "sentiment": 0, "count": 1, "label": "Spain", "uri": "https://diffbot.com/entity/AVgMpO16yNySigGdSXQEyZQ", "rdfTypes": ["http://dbpedia.org/ontology/Place", "http://dbpedia.org/ontology/PopulatedPlace", "http://dbpedia.org/ontology/Country"]}, {"score": 0.7325560450553894, "sentiment": 0, "count": 1, "label": "Berlin", "uri": "https://diffbot.com/entity/ANW5__a6aPOmyptf_BT8zXg", "rdfTypes": ["http://dbpedia.org/ontology/Place", "http://dbpedia.org/ontology/PopulatedPlace", "http://dbpedia.org/ontology/Settlement", "http://dbpedia.org/ontology/City", "http://dbpedia.org/ontology/State"]}, {"score": 0.7117617130279541, "sentiment": 0, "count": 1, "label": "Max Planck Institute for Infection Biology", "uri": "https://diffbot.com/entity/OZXM8HOKDOr6McldiBn8dFg", "rdfTypes": ["http://dbpedia.org/ontology/Organisation", "http://dbpedia.org/ontology/Place"]}], "publisherCountry": "United States", "humanLanguage": "en", "pageUrl": "https://news.yahoo.com/flu-outbreaks-may-linked-covid-192839579.html", "html": "<figure data-reactid=\"11\" data-type=\"image\"><img alt=\"Flu outbreaks may be linked to COVID-19; arthritis drug benefit seen\" data-reactid=\"15\" src=\"https://s.yimg.com/uu/api/res/1.2/ETMJyTIb.tgcUrC6mM4yuA--~B/aD01MzM7dz04MDA7c209MTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en-US/reuters.com/dbd3060cf3448e409e19f763ad5db7d0\"></img><figcaption>FILE PHOTO: An illustration, created at the Centers for Disease Control and Prevention (CDC), depicts the 2019 Novel Coronavirus</figcaption></figure>\n<p>By Nancy Lapid</p>\n<p>(Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.</p>\n<p>Flu may be linked with coronavirus spread</p>\n<p>Influenza outbreaks may be linked with the spread of COVID-19 infections, according to a European study.</p>\n<p>The researchers created a mathematical model of transmission of the novel coronavirus in Belgium, Italy, Norway and Spain. It calculates that higher rates of influenza infections would be associated with increased coronavirus transmission in each of the countries, Matthieu Domenech de Cell&egrave;s of the Max Planck Institute for Infection Biology in Berlin told Reuters. He said the estimates, published on Wednesday on the medical website medRxiv in advance of peer review, align with earlier research.</p>\n<p>In Italy, he noted, higher rates of flu vaccination have been linked with lower rates of death from COVID-19. Also, he said, a U.S. study of nearly 11,700 people tested for COVID-19 found that those who had flu vaccines were less likely to have a positive test.</p>\n<p>None of these studies proves that flu vaccines affect spread of COVID-19 or an individual's risk for it, and other factors might explain the associations. Still, de Cell&egrave;s said, in advance of &quot;the upcoming 'twindemic'&quot; of seasonal flu and COVID-19 in the northern hemisphere, &quot;our results suggest the need to increase vaccination against influenza,&quot; which may not only reduce the burden of influenza but also limit COVID-19 cases. (https://bit.ly/2FjkK4H)</p>\n<p>Rheumatoid arthritis drug found to aid COVID-19 recovery</p>\n<p>Hospitalized COVID-19 patients being treated with Gilead Sciences Inc's antiviral medication remdesivir recovered about a day sooner, on average, if they also received Eli Lilly and Co's rheumatoid arthritis drug baricitinib, clinical trial investigators found.</p>\n<p>The trial, sponsored by the U.S. National Institute of Allergy and Infectious Diseases (NIAID), included more than 1,000 patients. The study also showed that compared to patients who did not receive the arthritis drug, those who did had better outcomes at 15 days after they enrolled in the trial. Based on the data, Lilly plans to discuss the potential for emergency-use authorization with the U.S. Food and Drug Administration. The company announced the results of the so-called ACTT-2trial in a news release on Monday. The results have not been formally published yet. (https://bit.ly/35vAEn8)</p>\n<figure><iframe src=\"https://cdn-ssl.vidible.tv/prod/player/ad-time/local-storage.html\"></iframe></figure>", "text": "More\nBy Nancy Lapid\n(Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.\nFlu may be linked with coronavirus spread\nInfluenza outbreaks may be linked with the spread of COVID-19 infections, according to a European study.\nThe researchers created a mathematical model of transmission of the novel coronavirus in Belgium, Italy, Norway and Spain. It calculates that higher rates of influenza infections would be associated with increased coronavirus transmission in each of the countries, Matthieu Domenech de Cell\u00e8s of the Max Planck Institute for Infection Biology in Berlin told Reuters. He said the estimates, published on Wednesday on the medical website medRxiv in advance of peer review, align with earlier research.\nIn Italy, he noted, higher rates of flu vaccination have been linked with lower rates of death from COVID-19. Also, he said, a U.S. study of nearly 11,700 people tested for COVID-19 found that those who had flu vaccines were less likely to have a positive test.\nNone of these studies proves that flu vaccines affect spread of COVID-19 or an individual's risk for it, and other factors might explain the associations. Still, de Cell\u00e8s said, in advance of \"the upcoming 'twindemic'\" of seasonal flu and COVID-19 in the northern hemisphere, \"our results suggest the need to increase vaccination against influenza,\" which may not only reduce the burden of influenza but also limit COVID-19 cases. (https://bit.ly/2FjkK4H)\nRheumatoid arthritis drug found to aid COVID-19 recovery\nHospitalized COVID-19 patients being treated with Gilead Sciences Inc's antiviral medication remdesivir recovered about a day sooner, on average, if they also received Eli Lilly and Co's rheumatoid arthritis drug baricitinib, clinical trial investigators found.\nThe trial, sponsored by the U.S. National Institute of Allergy and Infectious Diseases (NIAID), included more than 1,000 patients. The study also showed that compared to patients who did not receive the arthritis drug, those who did had better outcomes at 15 days after they enrolled in the trial. Based on the data, Lilly plans to discuss the potential for emergency-use authorization with the U.S. Food and Drug Administration. The company announced the results of the so-called ACTT-2trial in a news release on Monday. The results have not been formally published yet. (https://bit.ly/35vAEn8)"}]}